Welcome! Log into your account
Forgot your password? Get help
Recover your password
A password will be e-mailed to you.
ThiIrd Lynparza Indication in EU
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced the European Commission has approved Lynparza (olaparib) as a monotherapy ...
EU Advisors Recommend AstraZeneca and Merck’s Tablets
AstraZeneca and Merck, known as MSD outside the United States and Canada, announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positi...
AZ and MSD’s Drug Delays Pancreatic Cancer Progression
AstraZeneca and MSD Inc., Kenilworth, N.J., US (MSD: known as Merck & Co., Inc. inside the US and Canada) today announced positive results from the Phase III POLO trial. Results from the trial ...
Successful Trials of AstraZeneca’s Cancer and Anemia Drugs
British drugmaker AstraZeneca on Thursday said its ovarian cancer and anemia treatments met their goals in three separate late stage trials. The positive results provide a shot in the arm for the c...
Pharmasyntez Group of Companies
Rafarma – a full cycle pharmaceutical enterprise
Binnopharm – full-cycle biopharmaceutical faciliti...
Pharmacor Production Ltd.
R-Pharm – Russian High-Tech Pharmaceutical Enterprise
PIQ-PHARMA Group of Companies
Top 30 pharmaceutical contract manufacturing organisations
GMP Inspection practice: a case for global benchmarking, con...
Merck KGaA will lead Global Oncology Big Data Alliance
The Power of Steam: How to Remove Residues of Collagen from ...
Merck and Utah University Found Potential Drug Target for Di...
Cell Research of Russian, Chinese and American Scientists
Subscribe to Newsletter!
© GMP news